Drug repurposing in pediatrics and pediatric hematology oncology.
about
Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Drug-target interaction prediction by integrating chemical, genomic, functional and pharmacological data.The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.Repurposing medicinal compounds for blood cancer treatment.Expanding the scope of drug repurposing in pediatrics: the Children's Pharmacy Collaborative.Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Medication Repurposing in Pediatric Patients: Teaching Old Drugs New TricksAnti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.Gasotransmitters in cancer: from pathophysiology to experimental therapy.Metronomics: towards personalized chemotherapy?Drug repurposing in oncology--patient and health systems opportunities.Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside StudyDisulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition.Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
P2860
Q30239861-81BC185A-7980-406F-BF03-8D06B007614DQ30705795-80EE6AFB-D199-47E6-B550-942EFF6A6EB5Q33566593-28EBD7D6-908A-4A9D-B962-5467D2E1F65FQ33611069-67100DD7-E664-4B12-9114-FCC3C77E72FAQ35807959-5A7EEBA8-837D-4DAF-A034-D0CEC4DB08D3Q36083201-98BB0C83-E5DD-4422-BB27-17B9E3BABFB7Q36225879-3BD29256-8E14-4626-8F45-8D2EA559DC66Q36652800-031D9C70-5ACD-4601-AC92-774989C0D6F2Q37649652-868C8CBF-46AB-4744-BE05-41692FF523E0Q37656625-D6795881-B523-4966-A493-DA2239FE6EEDQ38218923-1A628E74-309B-4D79-9DA4-76CC43B39151Q38611707-7F174464-72D1-41B3-829C-E5779868D18DQ38769283-043796A8-F144-49A0-ACB3-CAD4B410AE6EQ41575123-21B4FA89-28E5-48DB-AF34-68177F8049FDQ50005505-B669C2B0-8324-4BB6-A39C-CFC328C98314
P2860
Drug repurposing in pediatrics and pediatric hematology oncology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug repurposing in pediatrics and pediatric hematology oncology.
@en
type
label
Drug repurposing in pediatrics and pediatric hematology oncology.
@en
prefLabel
Drug repurposing in pediatrics and pediatric hematology oncology.
@en
P1433
P1476
Drug repurposing in pediatrics and pediatric hematology oncology.
@en
P2093
Julie Blatt
Seth J Corey
P356
10.1016/J.DRUDIS.2012.07.009
P577
2012-07-23T00:00:00Z